During the past decade, Western Health conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Western Health" #1 sponsor was "Incyte Corporation" with 2 trials, followed by "Neuroscience Trials Australia" with 2 trials sponsored, "Amplia Therapeutics Limited" with 1 trials sponsored, "Australasian Gastro-Intestinal Trials Group" with 1 trials sponsored and "Dart NeuroScience, LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Western Health" #1 collaborator was "The Florey Institute of Neuroscience and Mental Health" with 2 trials as a collaborator, "Australasian Society for Infectious Diseases" with 1 trials as a collaborator, "Aveiro University" with 1 trials as a collaborator, "Dalhousie University" with 1 trials as a collaborator and "Hunter Medical Research Institute" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Western Health" are "Ischemic Stroke" (3 trials), "COVID-19" (1 trials), "Chronic Kidney Diseases" (1 trials), "Colorectal Cancer Metastatic" (1 trials) and "Copd" (1 trials). Many other conditions were trialed in "Western Health" in a lesser frequency.

Most popular intervention types in "Western Health" are "Drug" (10 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Tenecteplase" (2 trials), "AMP945 RP2D" (1 trials), "AMP945 ascending doses" (1 trials) and "AT-1501" (1 trials). Other intervention names were less common.

The vast majority of trials in "Western Health" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Western Health". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Western Health, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Western Health, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".